{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T16:53:54Z","timestamp":1772038434429,"version":"3.50.1"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T00:00:00Z","timestamp":1751587200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T00:00:00Z","timestamp":1751587200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["001"],"award-info":[{"award-number":["001"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Epidermolysis bullosa (EB) presents various complications that can affect an individual\u2019s health-related quality of life (HRQoL) and nutritional status. This cross-sectional study evaluates HRQoL and its association with the socio-demographic, nutritional, and clinical profiles of Brazilians with EB.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The sample consisted of 129 individuals (median age: 15 years), approximately 57% female, mostly composed of the EB simplex clinical type, followed by the dystrophic EB type (DEB). The mean score on the Children\u2019s Dermatology Life Quality Index questionnaire was 11.01 [standard deviation (SD)\u2009=\u20097.31], with a moderate impact on HRQoL. The median and interquartile range (IQR) of the score obtained in the Quality of Life Evaluation in Epidermolysis Bullosa\u2013 Brazilian Portuguese questionnaire was 13 (IQR: 8\u201319), which also indicated a moderate impact on HRQoL. In the subgroup aged\u2009\u2265\u200917 years, schooling positively influenced HRQoL, and decreased HRQoL was directly associated with underweight nutritional status. Family income promoted HRQoL in both subgroups.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>HRQoL assessment showed that the DEB type was associated with the most severe effect. Additionally, the large impact, in &lt;\u200917 years, was associated with family income, but did not present an association with nutritional status. While the severe impact on HRQoL, in \u2265\u200917 years, presented an association with nutritional status, family income, and education. Future research is important, to understand this population\u2019s needs, provide adequate care, and promote the best HRQoL.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13023-025-03753-w","type":"journal-article","created":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T13:47:18Z","timestamp":1751636838000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The health-related quality of life of Brazilians with epidermolysis bullosa"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9979-1812","authenticated-orcid":false,"given":"Camille Cristine Gomes","family":"Togo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8071-4043","authenticated-orcid":false,"given":"Ana Paula Caio","family":"Zid\u00f3rio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6893-8263","authenticated-orcid":false,"given":"Vivian Siqueira Santos","family":"Gon\u00e7alves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2264-6331","authenticated-orcid":false,"given":"Eliane Said","family":"Dutra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,4]]},"reference":[{"key":"3753_CR1","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1111\/exd.13668","volume":"28","author":"C Has","year":"2019","unstructured":"Has C, Fischer J. Inherited epidermolysis Bullosa: new diagnostics and new clinical phenotypes. Exp Dermatol. 2019;28:1146\u201352.","journal-title":"Exp Dermatol"},{"key":"3753_CR2","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1186\/s13023-022-02462-y","volume":"17","author":"PJ Mauritz","year":"2022","unstructured":"Mauritz PJ, Bolling M, Duipmans JC, Hagedoorn M. Patients\u2019 and parents\u2019 experiences during wound care of epidermolysis Bullosa from a dyadic perspective: a survey study. Orphanet J Rare Dis. 2022;17:313.","journal-title":"Orphanet J Rare Dis"},{"key":"3753_CR3","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1111\/bjd.18921","volume":"183","author":"C Has","year":"2020","unstructured":"Has C, Bauer JW, Bodemer C, Bolling MC, Bruckner-Tuderman L, Diem A, et al. Consensus reclassification of inherited epidermolysis Bullosa and other disorders with skin fragility. Br J Dermatol. 2020;183:614\u201327.","journal-title":"Br J Dermatol"},{"key":"3753_CR4","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1001\/jamadermatol.2016.2473","volume":"152","author":"J Fine","year":"2016","unstructured":"Fine J. Epidemiology of inherited epidermolysis Bullosa based on incidence and prevalence estimates from the National epidermolysis Bullosa registry. JAMA Dermatol. 2016;152:1231\u20138.","journal-title":"JAMA Dermatol"},{"key":"3753_CR5","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1111\/jdv.17012","volume":"35","author":"R Baardman","year":"2021","unstructured":"Baardman R, Yenamandra VK, Duipmans JC, Pasmooij AMG, Jonkman MF, Akker PC, et al. Novel insights into the epidemiology of epidermolysis Bullosa (EB) from the Dutch EB registry: EB more common than previously assumed? J Eur Acad Dermatol Venereol. 2021;35:995\u20131006.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"3753_CR6","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1111\/jdv.18637","volume":"37","author":"C Has","year":"2023","unstructured":"Has C, Hess M, Anem\u00fcller W, Blume-Peytavi U, Emmert S, F\u00f6lster\u2010Holst R, et al. Epidemiology of inherited epidermolysis Bullosa in Germany. J Eur Acad Dermatology Venereol. 2023;37:402\u201310.","journal-title":"J Eur Acad Dermatology Venereol"},{"key":"3753_CR7","unstructured":"BRASIL. Minist\u00e9rio da Sa\u00fade. Diretrizes Brasileiras para os Cuidados de Pacientes com Epiderm\u00f3lise Bolhosa. 2021. Available from: https:\/\/www.gov.br\/conitec\/pt-br\/midias\/relatorios\/2021\/20211231_relatorio_683_diretrizes_brasileiras_eb_final.pdf"},{"key":"3753_CR8","unstructured":"DEBRA. Dystrophic Epidermolysis Bullosa Research Association of America - Brasil. 2022. Available from: https:\/\/debrabrasil.com.br\/"},{"key":"3753_CR9","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.jaad.2009.03.052","volume":"61","author":"J-D Fine","year":"2009","unstructured":"Fine J-D, Mellerio JE. Extracutaneous manifestations and complications of inherited epidermolysis Bullosa: part I. Epithelial associated tissues. J Am Acad Dermatol Elsevier. 2009;61:367\u201384.","journal-title":"J Am Acad Dermatol Elsevier"},{"key":"3753_CR10","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.clnu.2019.02.023","volume":"39","author":"S Salera","year":"2020","unstructured":"Salera S, Tadini G, Rossetti D, Grassi FS, Marchisio P, Agostoni C, et al. A nutrition-based approach to epidermolysis Bullosa: causes, assessments, requirements and management. Clin Nutr. 2020;39:343\u201352.","journal-title":"Clin Nutr"},{"key":"3753_CR11","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1590\/1413-81232018233.08002016","volume":"23","author":"DSM da Cruz","year":"2018","unstructured":"da Cruz DSM, Collet N, N\u00f3brega VM. Quality of life related to health of adolescents with dm1: an integrative review. Cien Saude Colet. 2018;23:973\u201389.","journal-title":"Cien Saude Colet"},{"key":"3753_CR12","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1056\/NEJM199603283341306","volume":"334","author":"MA Testa","year":"1996","unstructured":"Testa MA, Simonson DC. Assessment of quality-of-life outcomes. N Engl J Med. 1996;334:835\u201340.","journal-title":"N Engl J Med"},{"key":"3753_CR13","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1136\/bmj.316.7130.542","volume":"316","author":"MF Muldoon","year":"1998","unstructured":"Muldoon MF, Barger SD, Flory JD, Manuck SB. What are quality of life measurements measuring? BMJ. 1998;316:542\u20135.","journal-title":"BMJ"},{"key":"3753_CR14","doi-asserted-by":"publisher","first-page":"2726","DOI":"10.1038\/sj.jid.5701142","volume":"127","author":"H Both","year":"2007","unstructured":"Both H, Essink-Bot M, Busschbach J, Nijsten T. Critical review of generic and dermatology-specific health-related quality of life instruments. J Invest Dermatol. 2007;127:2726\u201339.","journal-title":"J Invest Dermatol"},{"key":"3753_CR15","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1002\/9780470692004.ch24","volume-title":"Clin paediatr diet","author":"L Haynes","year":"2007","unstructured":"Haynes L. Epidermolysis Bullosa. In: Shaw V, Lawson M, editors. Clin paediatr diet. 3rd ed. Oxford, UK: Blackwell Publishing Ltd; 2007. pp. 482\u201396.","edition":"3"},{"key":"3753_CR16","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1016\/j.jaad.2014.01.903","volume":"70","author":"J Fine","year":"2014","unstructured":"Fine J, Bruckner-Tuderman L, Eady RAJ, Bauer EA, Bauer JW, Has C, et al. Inherited epidermolysis Bullosa: updated recommendations on diagnosis and classification. J Am Acad Dermatol Elsevier. 2014;70:1103\u201326.","journal-title":"J Am Acad Dermatol Elsevier"},{"key":"3753_CR17","doi-asserted-by":"crossref","unstructured":"Hubbard L, Haynes L, Sklar M, Martinez AE, Mellerio JE. The challenges of meeting nutritional requirements in children and adults with epidermolysis bullosa: Proceedings of a multidisciplinary team study day. Clin Exp Dermatol. 2011;36:579\u201383.","DOI":"10.1111\/j.1365-2230.2011.04091.x"},{"key":"3753_CR18","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1001\/archderm.1989.01670150064009","volume":"125","author":"J Fine","year":"1989","unstructured":"Fine J, Tamura T, Johnson L. Blood vitamin and trace metal levels in epidermolysis Bullosa. Arch Dermatol. 1989;125:374\u20139.","journal-title":"Arch Dermatol"},{"key":"3753_CR19","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1111\/j.1468-3083.2004.01067.x","volume":"18","author":"S Ingen-Housz-Oro","year":"2004","unstructured":"Ingen-Housz-Oro S, Blanchet-Bardon C, Vrillat M, Dubertret L. Vitamin and trace metal levels in recessive dystrophic epidermolysis Bullosa. J Eur Acad Dermatology Venereol. 2004;18:649\u201353.","journal-title":"J Eur Acad Dermatology Venereol"},{"key":"3753_CR20","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","volume":"61","author":"E von Elm","year":"2008","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol. 2008;61:344\u20139.","journal-title":"J Clin Epidemiol"},{"key":"3753_CR21","first-page":"72","volume":"5","author":"KS Badger","year":"2013","unstructured":"Badger KS, O\u2019Haver J, Price H. Recommendations for a comprehensive management plan for the child diagnosed with epidermolysis Bullosa. J Dermatol Nurs. 2013;5:72\u20138.","journal-title":"J Dermatol Nurs"},{"key":"3753_CR22","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.jaad.2012.01.016","volume":"67","author":"E Pope","year":"2012","unstructured":"Pope E, Lara-Corrales I, Mellerio J, Martinez A, Schultz G, Burrell R, et al. A consensus approach to wound care in epidermolysis Bullosa. J Am Acad Dermatol. 2012;67:904\u201317.","journal-title":"J Am Acad Dermatol"},{"key":"3753_CR23","doi-asserted-by":"publisher","first-page":"143","DOI":"10.2340\/00015555-0376","volume":"88","author":"A Lettinga","year":"2008","unstructured":"Lettinga A, Duipmans J, Maathuis C, Jonkman M. Main problems experienced by children with epidermolysis Bullosa: a qualitative study with Semi-structured interviews. Acta Derm Venereol. 2008;88:143\u201350.","journal-title":"Acta Derm Venereol"},{"key":"3753_CR24","volume-title":"WHO child growth standards: Length\/height-for-age, weight-for-age, weight-for-length, weight-for-height and body mass index-for-age","author":"WHO","year":"2006","unstructured":"WHO. WHO child growth standards: Length\/height-for-age, weight-for-age, weight-for-length, weight-for-height and body mass index-for-age. Geneva: Methods and development; 2006."},{"key":"3753_CR25","doi-asserted-by":"publisher","first-page":"660","DOI":"10.2471\/BLT.07.043497","volume":"85","author":"M de Onis","year":"2007","unstructured":"de Onis M. Development of a WHO growth reference for school-aged children and adolescents. Bull World Health Organ. 2007;85:660\u20137.","journal-title":"Bull World Health Organ"},{"key":"3753_CR26","unstructured":"WHO. Physical status: the use and interpretation of anthropometry. Geneva; 1995."},{"key":"3753_CR27","doi-asserted-by":"publisher","unstructured":"Salek MS, Jung S, Brincat-Ruffini LA, MacFarlane L, Lewis-Jones MS, Basra MK, Finlay AY. Clinical experience and psychometric properties of the Children's Dermatology Life Quality Index (CDLQI), 1995\u20132012. Br J Dermatol. 2013;169(4):734\u201359. https:\/\/doi.org\/10.1111\/bjd.12437. PMID: 23679682.","DOI":"10.1111\/bjd.12437"},{"key":"3753_CR28","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1111\/j.1365-2133.1995.tb16953.x","volume":"132","author":"MS Lewis-Jones","year":"1995","unstructured":"Lewis-Jones MS, Finlay AY. The children\u2019s dermatology life quality index (CDLQI): initial validation and practical use. Br J Dermatol. 1995;132:942\u20139.","journal-title":"Br J Dermatol"},{"key":"3753_CR29","unstructured":"Waters A,  Sandhu D, Beattie P, Ezughah F, Lewis-Jones S. Severity stratification of Children\u2019s dermatology life quality index (CDLQI) scores. 2010;121\u2013121."},{"key":"3753_CR30","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1111\/j.1365-2133.2009.09347.x","volume":"161","author":"JW Frew","year":"2009","unstructured":"Frew JW, Martin LK, Nijsten T, Murrell DF. Quality of life evaluation in epidermolysis Bullosa (EB) through the development of the QOLEB questionnaire: an EB-specific quality of life instrument. Br J Dermatol. 2009;161:1323\u201330.","journal-title":"Br J Dermatol"},{"key":"3753_CR31","doi-asserted-by":"publisher","first-page":"e94","DOI":"10.1111\/ijd.12819","volume":"55","author":"T Cestari","year":"2016","unstructured":"Cestari T, Prati C, Menegon DB, Prado Oliveira ZN, Machado MCR, Dumet J, et al. Translation, cross-cultural adaptation and validation of the quality of life evaluation in epidermolysis Bullosa instrument in Brazilian Portuguese. Int J Dermatol. 2016;55:e94\u20139.","journal-title":"Int J Dermatol"},{"key":"3753_CR32","doi-asserted-by":"publisher","first-page":"68","DOI":"10.33204\/mucosa.598339","volume":"2","author":"J Frew","year":"2019","unstructured":"Frew J, Murrell D. Improving clinical applications of quality of life scores in epidermolysis Bullosa: defining clinically significant outcomes in the QOLEB questionnaire. Mucosa. 2019;2:68\u201375.","journal-title":"Mucosa"},{"key":"3753_CR33","unstructured":"StataCorp. 2019. Stata Statistical Software: Release 16. College Station, TX: StataCorp LLC. College Station, Texas: StataCorp LLC; 2019."},{"key":"3753_CR34","unstructured":"IDEC. Acesso \u00e0 internet na regi\u00e3o Norte do Brasil. Inst. Bras. Def. do Consum. e Derechos Digit. 2022. Available from: https:\/\/idec.org.br\/pesquisas-acesso-internet"},{"key":"3753_CR35","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1001\/jamadermatol.2018.4673","volume":"155","author":"JA Feinstein","year":"2019","unstructured":"Feinstein JA, Jambal P, Peoples K, Lucky AW, Khuu P, Tang JY, et al. Assessment of the timing of milestone clinical events in patients with epidermolysis Bullosa from North America. JAMA Dermatology. 2019;155:196.","journal-title":"JAMA Dermatology"},{"key":"3753_CR36","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1111\/bjd.18128","volume":"182","author":"C Has","year":"2020","unstructured":"Has C, Liu L, Bolling MC, Charlesworth AV, El Hachem M, Esc\u00e1mez MJ, et al. Clinical practice guidelines for laboratory diagnosis of epidermolysis Bullosa. Br J Dermatol. 2020;182:574\u201392.","journal-title":"Br J Dermatol"},{"key":"3753_CR37","unstructured":"BRASIL. Minist\u00e9rio da Sa\u00fade. CONITEC. Protocolo Cl\u00ednico e Diretrizes Terap\u00eauticas da Epiderm\u00f3lise Bolhosa Heredit\u00e1ria e Adquirida. Bras. Minist\u00e9rio da Sa\u00fade. 2020. Available from: https:\/\/www.gov.br\/saude\/pt-br\/assuntos\/pcdt\/arquivos\/2020\/epidermolise-bolhosa-hereditaria-e-adquirida-pcdt.pdf"},{"key":"3753_CR38","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.abd.2020.05.015","volume":"96","author":"LM Mariath","year":"2021","unstructured":"Mariath LM, Kiszewski AE, Frantz JA, Siebert M, Matte U, Schuler-Faccini L. Gene panel for the diagnosis of epidermolysis Bullosa: proposal for a viable and efficient approach. Bras Dermatol. 2021;96:155\u201362.","journal-title":"Bras Dermatol"},{"key":"3753_CR39","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1016\/j.jaad.2020.03.028","volume":"85","author":"VA Eng","year":"2021","unstructured":"Eng VA, Solis DC, Gorell ES, Choi S, Nazaroff J, Li S, et al. Patient-reported outcomes and quality of life in recessive dystrophic epidermolysis Bullosa: a global cross-sectional survey. J Am Acad Dermatol. 2021;85:1161\u20137.","journal-title":"J Am Acad Dermatol"},{"key":"3753_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13023-019-1279-y","volume":"15","author":"AL Bruckner","year":"2020","unstructured":"Bruckner AL, Losow M, Wisk J, Patel N, Reha A, Lagast H, et al. The challenges of living with and managing epidermolysis Bullosa: insights from patients and caregivers. Orphanet J Rare Dis. 2020;15:1.","journal-title":"Orphanet J Rare Dis"},{"key":"3753_CR41","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/j.jaad.2008.02.004","volume":"58","author":"J-D Fine","year":"2008","unstructured":"Fine J-D, Eady RAJ, Bauer EA, Bauer JW, Bruckner-Tuderman L, Heagerty A, et al. The classification of inherited epidermolysis Bullosa (EB): report of the third international consensus meeting on diagnosis and classification of EB. J Am Acad Dermatol. 2008;58:931\u201350.","journal-title":"J Am Acad Dermatol"},{"key":"3753_CR42","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1111\/bjd.15221","volume":"176","author":"VK Yenamandra","year":"2017","unstructured":"Yenamandra VK, Moss C, Sreenivas V, Khan M, Sivasubbu S, Sharma VK, et al. Development of a clinical diagnostic matrix for characterizing inherited epidermolysis Bullosa. Br J Dermatol. 2017;176:1624\u201332.","journal-title":"Br J Dermatol"},{"key":"3753_CR43","unstructured":"BRASIL.Minist\u00e9rio da Sa\u00fade. Portaria no 199, de 30 de janeiro de 2014. Available from: https:\/\/www.gov.br\/saude\/pt-br\/composicao\/saes\/doencas-raras\/legislacao\/portaria-no-199-de-30-de-janeiro-de-2014"},{"key":"3753_CR44","unstructured":"BRASIL. Minist\u00e9rio da Sa\u00fade. Diretrizes para Aten\u00e7\u00e3o Integral \u00e0s Pessoas com Doen\u00e7as Raras no Sistema \u00danico de Sa\u00fade - SUS. Minist. da Saude - Portaria. 2014. Available from: https:\/\/bvsms.saude.gov.br\/bvs\/publicacoes\/diretrizes_atencao_integral_pessoa_doencas_raras_SUS.pdf"},{"key":"3753_CR45","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/1750-1172-9-76","volume":"9","author":"M El Hachem","year":"2014","unstructured":"El Hachem M, Zambruno G, Bourdon-Lanoy E, Ciasulli A, Buisson C, Hadj-Rabia S, et al. Multicentre consensus recommendations for skin care in inherited epidermolysis Bullosa. Orphanet J Rare Dis. 2014;9:76.","journal-title":"Orphanet J Rare Dis"},{"key":"3753_CR46","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s13023-017-0666-5","volume":"12","author":"J Brun","year":"2017","unstructured":"Brun J, Chiaverini C, Devos C, Leclerc-Mercier S, Mazereeuw J, Bourrat E, et al. Pain and quality of life evaluation in patients with localized epidermolysis Bullosa simplex. Orphanet J Rare Dis. 2017;12:119.","journal-title":"Orphanet J Rare Dis"},{"key":"3753_CR47","doi-asserted-by":"publisher","first-page":"6","DOI":"10.5021\/ad.2016.28.1.6","volume":"28","author":"IK Jeon","year":"2016","unstructured":"Jeon IK, On HR, Kim S-C. Quality of life and economic burden in recessive dystrophic epidermolysis Bullosa. Ann Dermatol. 2016;28:6\u201314.","journal-title":"Ann Dermatol"},{"key":"3753_CR48","doi-asserted-by":"publisher","first-page":"528","DOI":"10.12968\/jowc.2012.21.11.528","volume":"21","author":"T Adni","year":"2012","unstructured":"Adni T, Martin K, Mudge E. The psychosocial impact of chronic wounds on patients with severe epidermolysis Bullosa. J Wound Care. 2012;21:528\u201338.","journal-title":"J Wound Care"},{"key":"3753_CR49","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/pde.12243","volume":"31","author":"AY Kirkorian","year":"2014","unstructured":"Kirkorian AY, Weitz NA, Tlougan B, Morel KD. Evaluation of wound care options in patients with recessive dystrophic epidermolysis Bullosa: A costly necessity. Pediatr Dermatol. 2014;31:33\u20137.","journal-title":"Pediatr Dermatol"},{"key":"3753_CR50","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1111\/j.1365-2230.2004.01428.x","volume":"29","author":"J Fine","year":"2004","unstructured":"Fine J, Johnson LB, Weiner M, Suchindran C. Assessment of mobility, activities and pain in different subtypes of epidermolysis Bullosa. Clin Exp Dermatol. 2004;29:122\u20137.","journal-title":"Clin Exp Dermatol"},{"key":"3753_CR51","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1046\/j.1365-2230.2002.01121.x","volume":"27","author":"HM Horn","year":"2002","unstructured":"Horn HM, Tidman MJ. Quality of life in epidermolysis Bullosa. Clin Exp Dermatol. 2002;27:707\u201310.","journal-title":"Clin Exp Dermatol"},{"key":"3753_CR52","unstructured":"Denyer J, Pillay E, Clapham J. Best Practice Guidelines: Skin and wound care in Epidermolysis Bullosa. Wounds Int. 2017; Available from: https:\/\/woundsinternational.com\/best-practice-statements\/best-practice-guidelines-skin-and-wound-care-in-epidermolysis-bullosa\/"},{"key":"3753_CR53","unstructured":"Haynes L. Clinical practice guidelines for nutrition support in infants and children with epidermolysis bullosa (EB). Gt. Orm. Str. Hosp. 2007."},{"key":"3753_CR54","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s13052-022-01252-3","volume":"48","author":"C Retrosi","year":"2022","unstructured":"Retrosi C, Diociaiuti A, De Ranieri C, Corbeddu M, Carnevale C, Giancristoforo S, et al. Multidisciplinary care for patients with epidermolysis Bullosa from birth to adolescence: experience of one Italian reference center. Ital J Pediatr. 2022;48:58.","journal-title":"Ital J Pediatr"},{"key":"3753_CR55","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.jaad.2003.09.026","volume":"50","author":"DT Devries","year":"2004","unstructured":"Devries DT, Johnson LB, Weiner M, Fine J. Relative extent of skin involvement in inherited epidermolysis Bullosa (EB): composite regional anatomic diagrams based on the findings of the National EB registry, 1986 to 2002. J Am Acad Dermatol. 2004;50:572\u201381.","journal-title":"J Am Acad Dermatol"},{"key":"3753_CR56","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.ijwd.2020.05.012","volume":"6","author":"A Yazdanshenas","year":"2020","unstructured":"Yazdanshenas A, Naderi E, Moravvej H, Heidari K, Faghankhani M, Vahidnezhad H, et al. The quality of life in epidermolysis Bullosa (EB-QoL) questionnaire: translation, cultural adaptation, and validation into the Farsi Language. Int J Womens Dermatol. 2020;6:301\u20135.","journal-title":"Int J Womens Dermatol"},{"key":"3753_CR57","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1111\/j.1365-2133.2009.09306.x","volume":"161","author":"S Tabolli","year":"2009","unstructured":"Tabolli S, Sampogna F, Di Pietro C, Paradisi A, Uras C, Zotti P, et al. Quality of life in patients with epidermolysis Bullosa. Br J Dermatol. 2009;161:869\u201377.","journal-title":"Br J Dermatol"},{"key":"3753_CR58","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s13023-021-01702-x","volume":"16","author":"PJ Mauritz","year":"2021","unstructured":"Mauritz PJ, Bolling M, Duipmans JC, Hagedoorn M. The relationship between quality of life and coping strategies of children with EB and their parents. Orphanet J Rare Dis. 2021;16:53.","journal-title":"Orphanet J Rare Dis"},{"key":"3753_CR59","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.jaad.2013.04.053","volume":"69","author":"JW Frew","year":"2013","unstructured":"Frew JW, Cepeda Valdes R, Fortuna G, Murrell DF, Salas Alanis J. Measuring quality of life in epidermolysis Bullosa in Mexico: cross-cultural validation of the Hispanic version of the quality of life in epidermolysis Bullosa questionnaire. J Am Acad Dermatol. 2013;69:652\u20133.","journal-title":"J Am Acad Dermatol"},{"key":"3753_CR60","doi-asserted-by":"publisher","first-page":"442","DOI":"10.2340\/00015555-1758","volume":"94","author":"W Yuen","year":"2014","unstructured":"Yuen W, Frew J, Veerman K, Heuvel E, Murrell D, Jonkman M. Health-related quality of life in epidermolysis Bullosa: validation of the Dutch QOLEB questionnaire and assessment in the Dutch population. Acta Derm Venereol. 2014;94:442\u20137.","journal-title":"Acta Derm Venereol"},{"key":"3753_CR61","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1007\/s11136-020-02495-5","volume":"29","author":"CCG Togo","year":"2020","unstructured":"Togo CCG, Zidorio APC, Gon\u00e7alves VSS, Hubbard L, de Carvalho KMB, Dutra ES. Quality of life in people with epidermolysis Bullosa: a systematic review. Qual Life Res. 2020;29:1731\u201345.","journal-title":"Qual Life Res"},{"key":"3753_CR62","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/s13023-021-01811-7","volume":"16","author":"JY Tang","year":"2021","unstructured":"Tang JY, Marinkovich MP, Lucas E, Gorell E, Chiou A, Lu Y, et al. A systematic literature review of the disease burden in patients with recessive dystrophic epidermolysis Bullosa. Orphanet J Rare Dis. 2021;16:175.","journal-title":"Orphanet J Rare Dis"},{"key":"3753_CR63","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1111\/bjd.18475","volume":"182","author":"A Reimer","year":"2020","unstructured":"Reimer A, Hess M, Schwieger-Briel A, Kiritsi D, Schauer F, Schumann H, et al. Natural history of growth and anaemia in children with epidermolysis Bullosa: a retrospective cohort study. Br J Dermatol. 2020;182:1437\u201348.","journal-title":"Br J Dermatol"},{"key":"3753_CR64","doi-asserted-by":"crossref","unstructured":"Filoni A, Bonamonte D, Cicco G, Panza R, Bisceglie V, Laforgia N. Nutritional impairment of neonates with epidermolysis bullosa: a retrospective study. Ital J Dermatol Venerol. 2022;157(4):330\u20134. 10.23736\/S2784-8671.22.07259-0. Epub 2022 Apr 7. PMID: 35389041.","DOI":"10.23736\/S2784-8671.22.07259-0"},{"key":"3753_CR65","doi-asserted-by":"publisher","first-page":"264","DOI":"10.3349\/ymj.2014.55.1.264","volume":"55","author":"K Kim","year":"2014","unstructured":"Kim K, Namgung R, Lee SM, Kim SC, Eun HS, Park MS, et al. Nutritional outcomes in children with epidermolysis Bullosa: the experiences of two centers in Korea. Yonsei Med J. 2014;55:264\u20139.","journal-title":"Yonsei Med J"},{"key":"3753_CR66","doi-asserted-by":"publisher","unstructured":"Togo CCG, Zid\u00f3rio APC, S\u00e1 NM, Dutra ES. Health-related quality of life and clinical severity in people with epidermolysis bullosa - a proposal for assessing nutritional compromise by body mass index (Birmingham Epidermolysis Bullosa Severity Score). Nutr Hosp. 2024;41(2):400\u20138. English. https:\/\/doi.org\/10.20960\/nh.04827. PMID: 38149521.","DOI":"10.20960\/nh.04827"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03753-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-025-03753-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03753-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T15:03:03Z","timestamp":1751641383000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-025-03753-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,4]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3753"],"URL":"https:\/\/doi.org\/10.1186\/s13023-025-03753-w","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,4]]},"assertion":[{"value":"19 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The questionnaire and methodology for this study were approved by the Human Research Ethics Committee of the University of Bras\u00edlia (ethics approval number: 2.870.738). Before participating in the study, all participants provided informed consent, which was obtained by the researchers.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"341"}}